









市场行情
/
股票
/
nasdaq-pen
/

Penumbra Inc

PEN

231.540USD

-1.830-0.78%

收盘 10/30, 16:00（美东）报价延迟15分钟

9.02B总市值

61.09市盈率 TTM



Penumbra Inc

231.540

-1.830-0.78%

概览公司财务分析

概览

公司

财务

分析

关于 Penumbra Inc 公司

Penumbra, Inc. 是一家医疗保健公司。该公司设计、开发、制造和销售产品，并拥有一系列产品，可解决市场上尚未满足需求的棘手医疗状况。该公司专注于开发、制造和销售供专科医生和医疗保健提供者使用的产品，以推动改善临床和健康结果。该公司专注于开发和构建其产品组合，包括血栓切除术、栓塞术、通路和沉浸式医疗保健技术。该公司关注的常见疾病包括肺栓塞、深静脉血栓形成、外周动脉闭塞、缺血性中风、急性冠状动脉综合征、与动静脉移植或瘘相关的血栓、动脉瘤和出血性中风。该公司主要通过其在美国、欧洲、加拿大和澳大利亚的直销组织以及在特定国际市场的分销商向医疗保健提供者销售其产品。

Penumbra Inc简介



公司代码PEN

公司名称Penumbra Inc

上市日期Sep 18, 2015

CEOMr. Adam Elsesser, J.D.

员工数量4500

证券类型Ordinary Share

年结日Sep 18

公司地址One Penumbra Place

城市ALAMEDA

上市交易所NYSE Consolidated

国家United States of America

邮编94502

电话15109952486

网址https://www.penumbrainc.com/

公司代码PEN

上市日期Sep 18, 2015

CEOMr. Adam Elsesser, J.D.

Penumbra Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Adam Elsesser, J.D.

Chairman of the Board, Chief Executive Officer

1.02M

+1.21%

Dr. Arani Bose, M.D.

Director

290.26K

-3.97%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

51.68K

-1.15%

Ms. Shruthi Narayan

President

26.96K

-4.58%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.82K

-1.03%

Ms. Surbhi Sarna

Independent Director

3.15K

-1.84%

Ms. Maggie S. Yuen

Chief Financial Officer

Mr. Thomas C. (Tom) Wilder, III

Presiding Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Adam Elsesser, J.D.

Chairman of the Board, Chief Executive Officer

1.02M

+1.21%

Dr. Arani Bose, M.D.

Director

290.26K

-3.97%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

51.68K

-1.15%

Ms. Shruthi Narayan

President

26.96K

-4.58%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Thrombectomy

230.26M

67.83%

Embolization and Access

109.20M

32.17%

地区USD

名称

营收

占比

United States

260.82M

76.83%

International

78.64M

23.17%

业务

地区

业务USD

名称

营收

占比

Thrombectomy

230.26M

67.83%

Embolization and Access

109.20M

32.17%

股东统计

更新时间: 10月22日周三

持股股东

股东类型

持股股东

占比

Fidelity Management & Research Company LLC

12.92%

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

9.25%

T. Rowe Price Associates, Inc.

3.44%

State Street Investment Management (US)

3.00%

其他

61.51%

持股股东

占比

Fidelity Management & Research Company LLC

12.92%

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

9.25%

T. Rowe Price Associates, Inc.

3.44%

State Street Investment Management (US)

3.00%

其他

61.51%

股东类型

持股股东

占比

Investment Advisor

60.23%

Investment Advisor/Hedge Fund

22.51%

Hedge Fund

5.08%

Individual Investor

3.73%

Pension Fund

1.88%

Research Firm

1.63%

Sovereign Wealth Fund

1.21%

Bank and Trust

0.52%

Private Equity

0.08%

其他

3.13%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

844

36.41M

93.36%

-2.48M

2025Q2

864

37.32M

95.72%

-2.83M

2025Q1

878

36.92M

95.33%

-3.44M

2024Q4

834

37.02M

96.10%

-3.78M

2024Q3

813

37.33M

96.12%

-2.93M

2024Q2

796

37.57M

96.93%

+395.13K

2024Q1

777

35.67M

92.18%

-2.09M

2023Q4

759

36.33M

94.13%

-67.98K

2023Q3

737

35.15M

91.46%

-2.09M

2023Q2

719

36.20M

94.64%

-1.94M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

5.04M

12.92%

+93.97K

+1.90%

Jun 30, 2025

The Vanguard Group, Inc.

3.85M

9.88%

+185.31K

+5.05%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

3.61M

9.25%

+78.78K

+2.23%

Jun 30, 2025

T. Rowe Price Associates, Inc.

1.34M

3.44%

+164.55K

+13.99%

Jun 30, 2025

State Street Investment Management (US)

1.17M

-26.92K

-2.25%

Jun 30, 2025

Elsesser (Adam)

1.02M

2.62%

+12.18K

+1.21%

Sep 03, 2025

Baillie Gifford & Co.

922.13K

2.36%

+233.13K

+33.84%

Jun 30, 2025

RTW Investments L.P.

863.55K

2.21%

+783.00

+0.09%

Jun 30, 2025

Fidelity Institutional Asset Management

818.24K

2.1%

-76.68K

-8.57%

Jun 30, 2025

Champlain Investment Partners, LLC

743.71K

1.91%

-126.21K

-14.51%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

Motley Fool Small-Cap Growth ETF

3.26%

Congress SMid Growth ETF

2.33%

SPDR S&P Health Care Equipment ETF

1.95%

First Trust Indxx Medical Devices ETF

1.84%

ROBO Global Healthcare Technology & Innovation ETF

1.71%

Invesco S&P MidCap Quality ETF

1.59%

Putnam Sustainable Future ETF

1.45%

iShares U.S. Medical Devices ETF

1.21%

First Trust Health Care Alphadex Fund

0.91%

Fidelity Women's Leadership ETF

0.78%

Motley Fool Small-Cap Growth ETF

占比3.26%

Congress SMid Growth ETF

占比2.33%

SPDR S&P Health Care Equipment ETF

占比1.95%

First Trust Indxx Medical Devices ETF

占比1.84%

ROBO Global Healthcare Technology & Innovation ETF

占比1.71%

Invesco S&P MidCap Quality ETF

占比1.59%

Putnam Sustainable Future ETF

占比1.45%

iShares U.S. Medical Devices ETF

占比1.21%

First Trust Health Care Alphadex Fund

占比0.91%

Fidelity Women's Leadership ETF

占比0.78%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

